Answer
The efavirenz component of efavirenz/emtricitabine/tenofovir disoproxil has a terminal half-life of 40–55 hours after multiple doses.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated
Sources checked